HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marcus Resch Selected Research

Carcinoma (Carcinomatosis)

8/2016Combretastatin A-4 derived 5-(1-methyl-4-phenyl-imidazol-5-yl)indoles with superior cytotoxic and anti-vascular effects on chemoresistant cancer cells and tumors.
12/2015Role of JNK and NF-κB in mediating the effect of combretastatin A-4 and brimamin on endothelial and carcinoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marcus Resch Research Topics

Disease

3Neoplasms (Cancer)
08/2016 - 04/2014
2Carcinoma (Carcinomatosis)
08/2016 - 12/2015
1Breast Neoplasms (Breast Cancer)
12/2015
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2014

Drug/Important Bio-Agent (IBA)

2indoleIBA
08/2016 - 04/2014
2fosbretabulin (combretastatin A4)IBA
08/2016 - 12/2015
1TubulinIBA
08/2016
1trioctyl phosphine oxide (TOPO)IBA
08/2016
1DNA (Deoxyribonucleic Acid)IBA
12/2015
1brimaminIBA
12/2015
1verubulinIBA
04/2014

Therapy/Procedure

1Therapeutics
08/2016